Communities from around the world continue to grapple with the novel coronavirus pandemic, with the mRNA COVID vaccine in its early distribution stages. TCP, in line with CDC requirements, stores and transports the vaccine at -21 degrees Centigrade, all while expanding to new U.S. cities.
|
HIALEAH, Fla., March 3, 2021 /PRNewswire/ -- Communities from around the world continue to grapple with the novel coronavirus pandemic, with the mRNA COVID vaccine in its early distribution stages. TCP, in line with CDC requirements, stores and transports the vaccine at -21 degrees Centigrade, all while expanding to new U.S. cities.
Public health officials indicate the vaccine must be stored and transported at no more than -20 degrees Centigrade, and that one major provider's vaccine can be subsequently be kept refrigerated from 2-8 degrees Centigrade (for up to 30 days) while another major provider's vaccine can be refrigerated for up to five days. TCP reminds the general public that researchers have learned gel packs cannot maintain the required refrigeration temperature range, or the -20-degree Centigrade frozen temperature requirement imposed by the CDC.
All of these incidences occurred during a shortage of mRNA COVID vaccines to our U.S. citizens. Enter TCP's Phase Change Materials (PCMs), which can reliably maintain refrigerated, frozen, and ultra-cold mRNA COVID vaccine temperatures depending on the application. Due to their effectiveness, TCP's PCMs are now being used to safely transport and store vaccines to a number of new sites across the United States:
Throughout, TCP leverages data loggers to maintain mRNA COVID vaccine temperature records. About Thermal Custom Packaging Contact:
SOURCE Thermal Custom Packaging LLC |
View original content to download multimedia: